Priligy May Have A Rival Soon
Written by Richard Simmons| Saturday, 05 June 2010| There are 3 comments
Following the release of Priligy in the United Kingdom to treat premature ejaculation other potential remedies have also been getting some attention. Probably the most likely contender to follow in the footsteps of Priligy is a drug that we have mentioned at Ukmedix News and which is at present code named PSD502. This medication is in fact a very simple formula which comprises of a mixture of lidocaine and prilocaine, two drugs which have already been given EMEA and FDA approval separately and which when combined can increase lovemaking times by five and a half times.
PSD502 which is administered in the form of a spray directly to the penis was discussed at the meeting of the American Urological Association Annual Meeting taking place in San Francisco. Dr Ira Sharlip a Professor of Urology from the University of California explained that results from clinical studies showed that PSD502 had serious potential and described the results as "very exciting".
PSD502 works by simply desensitizing the penile area so that climax is impeded. On the other hand the drug Priligy is a more sophisticated treatment which is taken in the form of a tablet and which regulates serotonin in the brain which is known to be a major cause of premature ejaculation.
Premature ejaculation is in fact the number one UK male sexual problem and more men suffer from it then erectile dysfunction. Priligy which has been described as the Viagra of premature ejaculation is helping thousands of men to control this embarrassing condition which has been known to destroy relationships and prevent some men from ever becoming sexually intimate.
It is estimated that around one and three men in the United Kingdom suffers from premature ejaculation and the problem is not only confined to young people but is observed in the same proportion right through to old age.
Fields marked with * are required.